Heartflow (HTFL) Research & Development (2024 - 2025)
Heartflow (HTFL) recorded quarterly Research & Development of $18.7 million in Q4 2025, up 7.91% quarter-over-quarter from $17.3 million in Q3 2025, and up 52.01% on a YoY basis from $12.3 million in Q4 2024.
Heartflow (HTFL) Research & Development (2024 - 2025) Analysis & Trends
Heartflow's Research & Development history runs 2 years deep, the most recent figure standing at $18.7 million for Q4 2025.
- In Q4 2025, Research & Development rose 52.01% year-over-year to $18.7 million; the TTM figure through Dec 2025 stood at $63.3 million (changed N/A YoY), while the FY2025 annual figure was $64.9 million, up 49.18% from the prior year.
- Research & Development was $18.7 million for Q4 2025 at Heartflow, up from $17.3 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $18.7 million in Q4 2025 to a low of $9.9 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 208.32 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 67.77 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 30.34 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 56.85 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 39.11 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 18.37 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 21.52 Mn |
| 10 | Heartflow | 1.24 Bn | 1.06 Bn | 39.06 Mn | 18.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.67 Mn |
| Sep 30, 2025 | 17.30 Mn |
| Jun 30, 2025 | 15.03 Mn |
| Dec 31, 2024 | 12.28 Mn |
| Sep 30, 2024 | 11.86 Mn |
| Jun 30, 2024 | 9.93 Mn |